Hisamitsu Shares Set to Climb Again on $2.9 Billion Buyout Bid

Hisamitsu Pharmaceutical Co. is set to climb to its daily trading limit for a second day after the Japanese maker of pain-relief patches announced it would go private in a...

By Kanoko Matsuyama, Hideki Suzuki, Taro Fuse · Bloomberg

Hisamitsu Pharmaceutical Co. is set to climb to its daily trading limit for a second day after the Japanese maker of pain-relief patches announced it would go private in a management buyout valued at about ¥457 billion ($2.9 billion).